Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study.

Adriana Linares BallesterosRoy Sanguino LoboJuan Camilo Villada Valencia Oscar Guillermo Arévalo-Leal Diana Constanza Plazas Hernández Nelson Aponte Barrios Iván Perdomo Ramírez

Published in: Colombia medica (Cali, Colombia) (2021)

Cancer therapeutic-related cardiac dysfunction is related to anthracycline cumulative dose. In this study, echocardiographic follow-up was useful to predict risk factors for early cardiac dysfunction.

Keyphrases

early onset
left ventricular
late onset
oxidative stress
bone marrow
papillary thyroid
heart failure
squamous cell carcinoma
squamous cell
left atrial
drug induced
clinical evaluation